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The chondrogenic master transcription factor Sox9 binds to





Sox9 is a high-mobility-group (HMG) DNA-binding domain
transcription factor which plays an essential role in chondro-
genesis and in transcriptional regulation of the type II
collagen gene. In humans, SOX9 haploinsufficiency results
in campomelic dysplasia, a lethal skeletal malformation
syndrome with XY sex reversal. Furthermore, in chimera
studies Sox9-/- cells were unable to express chondrocyte-
specific extracellular matrix genes. Matrilin-1 (also known
as CMP-cartilage matrix protein), one of the major non-
collagenous proteins in most cartilages, binds to aggrecan
and type II collagen. It is a homotrimer of 54-kDa subunits
assembled via a coiled-coil a-helix and stabilized by disulfide
bridges. Matrilin-1 is expressed almost exclusively in
chondrocytes, and may function as a bridging molecule
between two major macromolecular networks of cartilage.
The understanding of the transcriptional regulation of the
gene is still limited. To get further insight into the transcrip-
tional regulation of the gene and to analyze protein-DNA
interactions in vivo, we performed in vivo footprinting on the
chicken matrilin-1 gene. Ligation-Mediated PCR technique
(LMPCR) was introduced that allows the amplification of
DNA fragments between positions –227 and +140 and
detection of control elements. Chicken embryo chondrocytes
(CEC) in comparison with chicken embryo fibroblasts
(CEF), the non-expressing cell type, were subjected to in
vivo analysis in which the total genomic DNA underwent a
specific cleavage procedure carried out inside the cell. Sets
of experiments revealed tissue-specific binding of transcrip-
tion factors to the promoter and intronic control regions. For
example, a cartilage-specific protection was observed at an
inverted repeat carrying two putative Sox9-binding sites in
the promoter upstream region of the matrilin-1 gene. To
provide evidence that Sox9 is indeed involved in the tran-
scriptional regulation of the matrilin-1 gene, we designed
synthetic oligonucleotides (wild type and several mutant
ones) for gel retardation assays. In vitro analysis using
electrophoretic mobility shift and supershift assays con-
firmed the binding of Sox9 transcription factor to the identi-
fied control element. Furthermore, using in vivo footprinting,
we could prove tissue-specific binding of NFI family tran-
scription factors to the silencer elements SI and SII identified
previously.
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